Glaukos (GKOS) Net Margin (2014 - 2026)

Glaukos (GKOS) reported Net Margin of 13.14% for Q1 2026, up 385.0% year-over-year from 2.71% in Q1 2025, and down 129.39% quarter-over-quarter from 44.7% in Q4 2025.

Glaukos (GKOS) Net Margin (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Net Margin data on file, last reported at 13.14% in Q1 2026.

  • Net Margin for Q1 2026 came in at 13.14%, up 385.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.51% (down 442.0% YoY), and the FY2025 annual result was 1.96%, up 164.0% from the prior year.
  • Net Margin retreated to 13.14% in Q1 2026 per GKOS's latest filing, from 44.7% in the prior quarter.
  • Over five years, Net Margin peaked at 123.0% in Q4 2023 and troughed at 62.65% in Q2 2022.
  • A 5-year average of 1.58% and a median of 16.99% in 2025 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2025: Net Margin jumped 13081 bps in 2022, then sank 6340 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 98.08% in 2022, then gained by 25 bps to 123.0% in 2023, then declined by 12 bps to 108.1% in 2024, then sank by 59 bps to 44.7% in 2025, then sank by 129 bps to 13.14% in 2026.
  • Business Quant data shows GKOS's Net Margin at 13.14% in Q1 2026, 44.7% in Q4 2025, and 12.15% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.65%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.38%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 12.75%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 8.01%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Glaukos 7.55 Bn 7.45 Bn 117.23 Mn -13.14%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.14%
Dec 31, 2025 44.70%
Sep 30, 2025 -12.15%
Jun 30, 2025 -15.84%
Mar 31, 2025 -16.99%
Dec 31, 2024 108.10%
Sep 30, 2024 -22.15%
Jun 30, 2024 -52.82%
Mar 31, 2024 -47.70%
Dec 31, 2023 123.00%
Sep 30, 2023 -39.01%
Jun 30, 2023 -40.77%
Mar 31, 2023 -46.86%
Dec 31, 2022 98.08%
Sep 30, 2022 -38.63%
Jun 30, 2022 -62.65%
Mar 31, 2022 7.98%
Dec 31, 2021 -32.73%
Sep 30, 2021 8.34%
Jun 30, 2021 -22.39%